Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Roche Raises Illumina Bid to $51, Seeking Faster Deal
Illumina, the U.S. maker of gene-mapping tools, rose above Roche’s increased hostile takeover bid, indicating investors are betting that an even higher offer will come.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing